Artal Group S.A. Lexicon Pharmaceuticals, Inc. Transaction History
Artal Group S.A.
- $101 Million
- Q4 2024
A detailed history of Artal Group S.A. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 136,180,481 shares of LXRX stock, worth $96.7 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
136,180,481
Previous 136,180,481
-0.0%
Holding current value
$96.7 Million
Previous $214 Million
52.87%
% of portfolio
100.0%
Previous 100.0%
Shares
8 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Siren, L.L.C. New York, NY38.9MShares$27.6 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.02 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.38 Million0.02% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.56MShares$5.37 Million0.04% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $134M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...